inborn errors of protein metabolism
Metabolic · 2014–2024
6decisions
6medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 6 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| triglycerides, long chain with glucose polymer Treatment of proven inborn errors of protein metabolism in patients unable to meet their energy requirements with permitted food and formulae. | Nov 2024 | Recommended with restriction | none received |
| amino acid formula with vitamins and minerals (multiple formulations) Nutritional support for patients with inborn errors of protein metabolism (homocystinuria, phenylketonuria, tyrosinaemia, maple syrup urine disease) from three… | Jul 2021 | Recommended | unclear |
| carbohydrate, fat, vitamins, minerals and trace elements Proven inborn errors of protein metabolism. | Jul 2020 | Recommended with restriction | none received |
| triglycerides medium chain and long chain with glucose polymer Dietary management of proven inborn errors of protein metabolism. | Mar 2020 | Recommended with restriction | none received |
| carbohydrate formula with minerals Proven inborn errors of protein metabolism and proven inborn errors of fat metabolism. | Nov 2016 | Not recommended | none received |
| triglycerides long chain with glucose polymer Inborn errors of protein metabolism (IEM) in patients unable to meet their energy requirements with permitted food and formulae. | Jul 2014 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 6 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.